Aurora Spine received Notice of Allowance in the U.S. for its patent for Patient-Matched Interbody Implant Technology.
This patent will support the development of spinal implants that match the patient’s specific bone density based on a DEXA Scan/T-score. Aurora Spine patient-matched implants will be bone density specific and may be used on patients with osteoporotic bone.
“Today, we are extremely excited about this patent that will be issued. Aurora Spine is once again positioned to reshape the market through patent focused innovation and address the next advancement in spine surgery – DEXA Interbody Technology," said Trent Northcutt, President and Chief Executive Officer of Aurora Spine. “This patent will allow for the development of implants that will match a patient’s bone density. We have placed a lot of effort and time into validating the bone match technology and are prepared to immediately commence testing of this new innovation.”